Skip to content
DataLookout
Menu

PEARLNCT07675473

Pre-Emptive Parecoxib Sodium for Pain Control During CT-Guided Lung Nodule Localization

StatusActive, Not Recruiting
PhasePhase 4
SponsorLong Jiang
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 14 words Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Secondary endpoints: details revised at 3 of 3 entries
    • Study description revised
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Pain Intensity Assessed by Visual Analog Scale (VAS)
Timeframe: Immediately after the completion of the CT-guided hook wire puncture (within 5 minutes after the withdrawal of the guide needle).

Secondary (3)

Optimal Dosing Time Window for Pre-Emptive Analgesia
Overall Patient Satisfaction Score
Number of Participants Experiencing Localization-Related Complications

Arms and interventions

Parecoxib SodiumExperimental

Participants in this arm will receive a single intravenous dose of 40mg parecoxib sodium prior to the CT-guided hook wire localization procedure.

Normal SalinePlacebo comparator

Participants in this arm will receive a single intravenous dose of 0.9% normal saline (visually identical to the experimental drug) prior to the CT-guided hook wire localization procedure.

Drugs: PARECOXIB SODIUM, 0.9 % Normal Saline

Sites

1 site in 1 country

  • Shanghai Chest HospitalShanghai, Shanghai Municipality, China